| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 13 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 13 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 13 |
| 3 | CARBOPLATIN | 10 |
| 4 | METOPROLOL | 10 |
| 5 | METOPROLOL TARTRATE | 10 |
| 6 | GEMCITABINE HYDROCHLORIDE | 9 |
| 7 | METHYLPREDNISOLONE | 9 |
| 8 | METOPROLOL TARTRATE INJECTION | 9 |
| 9 | AMLODIPINE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROQUINONE | 2 | 0.0034 |
| 1 | PENTOXIFYLLINE | 7 | 0.0016 |
| 2 | ETOPOSIDE PHOSPHATE | 2 | 0.0012 |
| 3 | VINORELBINE | 3 | 0.0004 |
| 4 | METHYLCELLULOSE | 1 | 0.0004 |
| 5 | BETAMETHASONE DIPROPIONATE | 2 | 0.0003 |
| 6 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| 7 | BRIGATINIB | 1 | 0.0003 |
| 8 | GLUCAGON | 1 | 0.0002 |
| 9 | RIPRETINIB | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 15 |
| 1 | Alkylating Drug [EPC] | 13 |
| 2 | Corticosteroid [EPC] | 13 |
| 3 | 5-alpha Reductase Inhibitor [EPC] | 8 |
| 4 | Calcium Channel Blocker [EPC] | 8 |
| 5 | Dihydropyridine Calcium Channel Blocker [EPC] | 8 |
| 6 | Aromatase Inhibitor [EPC] | 7 |
| 7 | Blood Viscosity Reducer [EPC] | 7 |
| 8 | Proton Pump Inhibitor [EPC] | 7 |
| 9 | Kinase Inhibitor [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanin Synthesis Inhibitor [EPC] | 2 | 0.0018 |
| 1 | Blood Viscosity Reducer [EPC] | 7 | 0.0016 |
| 2 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 3 | 5-alpha Reductase Inhibitor [EPC] | 8 | 0.0001 |
| 4 | Estrogen Receptor Antagonist [EPC] | 3 | 0.0001 |
| 5 | Aromatase Inhibitor [EPC] | 7 | 0.0001 |
| 6 | Platinum-based Drug [EPC] | 15 | 0.0001 |
| 7 | Alkylating Drug [EPC] | 13 | 0.0001 |
| 8 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |